Link
Framework for Equitable Allocation of COVID-19 Vaccine
Organization: The National Academies of Science Engineering MedicineNational Academy of Medicine
Published: 2020
"In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time frame. Vaccination against this novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), offers the possibility of significantly reducing severe morbidity and mortality and transmission when deployed alongside other public health strategies and improved therapies." - Framework for Equitable Allocation of COVID-19 Vaccine
Product Type: Guide
Category:
Program Planning and Delivery,Policy,Vaccine Management,Immunization Policies,Allocation and Distribution,Evaluations,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Program Planning and DeliveryPolicy
Vaccine Management
Immunization Policies
Allocation and Distribution
Evaluations
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Health Care Professional
Population: Children (All)
Adolescents
Adults
Region: International
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.